***We sent this letter to Dr W M Garraway and his colleagues, whose reply is printed below.-ED, BMJ.
SIR,-The limitations inherent in conducting controlled trials of methods of providing health services, which we refer to in our paper, mean that we have no information on the criteria which were used to transfer a selected group of patients from medical units during the acute phase of rehabilitation. But we have been able to examine the results of standard clinical tests which were designed to predict outcome following acute stroke, and which will form the subject of a future publication.
No difference was found in the pattern of neurological impairment present in the transferred group compared with those patients remaining in medical units throughout. Therefore it may not be surprising that there was no difference in outcome between the two groups. Transferring stroke patients from medical units for further rehabilitation appears to be a common practice in Britain, and on the basis of our results these transfers should be arranged earlier rather than later if the full benefits of intensive therapy are to be realised. But (4) Many substances are photosensitisers. They include several fluorescent dyes (erythrosin B), some metabolites (for example, bilirubin and porphyrins, and drugs like phenothiazines, tetracyclines, sulphonamides, thiazides, nalidixic acid, frusemide, quinine, and anthracene).6 The topical application therefore of preparations containing another phototoxic compound, 5-methoxypsoralen, could lead to an increased photosensitivity in individuals already sensitised to solar radiation.
(5) All tanning aids contain sunscreens, which are substances designed to prevent
